共 50 条
- [42] RESPONSE TO NEOADJUVANT CHEMOTHERAPY IS ASSOCIATED WITH IMPROVED SURVIVAL IN UPPER TRACT UROTHELIAL CARCINOMA-AN UPPER TRACT COLLABORATIVE NETWORK (UCAN) STUDY JOURNAL OF UROLOGY, 2024, 211 (05): : E449 - E450
- [43] SURVIVAL OUTCOMES IN PATIENTS UNDERGOING NEOADJUVANT CHEMOTHERAPY FOR UPPER TRACT UROTHELIAL CELL CARCINOMA JOURNAL OF UROLOGY, 2013, 189 (04): : E366 - E367
- [45] TRENDS IN UTILIZATION OF NEOADJUVANT CHEMOTHERAPY FOR UPPER TRACT UROTHELIAL CARCINOMA IN THE NATIONAL CANCER DATABASE JOURNAL OF UROLOGY, 2016, 195 (04): : E24 - E24
- [47] TWO CYCLES OF NEOADJUVANT CHEMOTHERAPY IMPROVES SURVIVAL OF UPPER TRACT UROTHELIAL CARCINOMA PATIENTS JOURNAL OF UROLOGY, 2020, 203 : E1248 - E1249
- [49] Re: Comparative Effectiveness of Neoadjuvant Chemotherapy in Bladder and Upper Urinary Tract Urothelial Carcinoma JOURNAL OF UROLOGY, 2022, 207 (06): : 1346 - 1347
- [50] Carcinoma Following Neoadjuvant Chemotherapy Oncologic Outcomes in Patients with Residual Upper Tract Urothelial EUROPEAN UROLOGY ONCOLOGY, 2024, 7 (05): : 1061 - 1068